Conversion of very low density lipoprotein to low density lipoprotein. A metabolic study of apolipoprotein B kinetics in human subjects.
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
The interrelationship between apolipoprotein B in very low density lipoprotein (VLDL-B) and in low density lipoprotein (LDL-B) was studied in seven normal and hyperlipidemic men and women, with purified radioiodinated VLDL. The time-course of the appearance of radioactivity in LDL was followed. As the specific activity curves intersected at the masimal height of the LDL-B curve, it was inferred that all or most LDL-B peptide is derived from VLDL-B peptide. This transfer was further quantitated in seven normotriglyceridemic subjects by simultaneous i.v. injection of purified 131I-VLDL and 125I-LDL. By a deconvolution method, a quantitative description of the rate of entry of 131Ivldl-b into 131I-LDL-B was derived by analysis of 131I-LDL-B and 125I-ldl-b radioactivity in plasma. The results indicate that approximately 90% of VLDL-B mass is converted into LDL-B in subjects with normal serum triglyceride concentrations. The synthetic rates of VLDL-B and LDL-B peptide were simultaneously measured in six normal subjects, and two patients with heterozygous familial hypercholesterolemia (type IIa). The turnover rates for VLDL-B and LDL-B peptide were similar in these subjects. The findings in the three parts of this study were consistent with the view that most if not all VLDL-B is converted into LDL-B peptide, and most if not all LDL-B is derived from VLDL-B peptide in normotriglyceridemic subjects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Havel, R. J., Eder, H. A., & Bragdon, J. H. (1955) · Journal of Clinical Investigation · doi:10.1172/jci103182 · Cited by 8,760
Efficient Trace-labelling of Proteins with Iodine
McFARLANE, A. S. (1958) · Nature · doi:10.1038/182053a0 · Cited by 2,543
A rapid, sensitive, and specific method for the determination of protein in dilute solution
Schaffner, W., & Weissmann, C. (1973) · Analytical Biochemistry · doi:10.1016/0003-2697(73)90217-0 · Cited by 2,509
Bilheimer, D. W., Eisenberg, S., & Levy, R. I. (1972) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(72)90034-3 · Cited by 1,818
The Theory of Tracer Experiments with 131I-Labelled Plasma Proteins
Matthews, C. M. E. (1957) · Physics in Medicine & Biology · doi:10.1088/0031-9155/2/1/305 · Cited by 829
Classification of Hyperlipidaemias and Hyperlipoproteinaemias ,
(1972) · Standard Methods of Clinical Chemistry · doi:10.1016/b978-0-12-609107-6.50016-7 · Cited by 820
The metabolism of low density lipoprotein in familial type II hyperlipoproteinemia
Langer, T., Strober, W., & Levy, R. I. (1972) · Journal of Clinical Investigation · doi:10.1172/jci106949 · Cited by 629
Zilversmit, D. B., Entenman, C., & Fishler, M. C. (1943) · Journal of General Physiology · doi:10.1085/jgp.26.3.325 · Cited by 529
Studies of the Proteins in Human Plasma Very Low Density Lipoproteins
Brown, W. V., Levy, R. I., & Fredrickson, D. S. (1969) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)63614-2 · Cited by 464
Cited by
Atherogenesis: a postprandial phenomenon.
Zilversmit, D. B. (1979) · Circulation · doi:10.1161/01.cir.60.3.473 · Cited by 1,701
High density lipoprotein metabolism.
Eisenberg, S. (1984) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37713-0 · Cited by 1,210
Phillipson, B. E., Rothrock, D. W., Connor, W. E., Harris, W. S., & Illingworth, D. R. (1985) · New England Journal of Medicine · doi:10.1056/nejm198505093121902 · Cited by 847
Regulation of Plasma Cholesterol by Lipoprotein Receptors
Brown, M. S., Kovanen, P. T., & Goldstein, J. L. (1981) · Science · doi:10.1126/science.6261329 · Cited by 702
Heterogeneity of apolipoprotein B: isolation of a new species from human chylomicrons.
Kane, J. P., Hardman, D. A., & Paulus, H. E. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.5.2465 · Cited by 584
Discoidal bilayer structure of nascent high density lipoproteins from perfused rat liver.
Hamilton, R. L., Williams, M. C., Fielding, C. J., & Havel, R. J. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108513 · Cited by 537
Lipoprotein apoprotein metabolism.
Schaefer, E. J., Eisenberg, S., & Levy, R. I. (1978) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41267-2 · Cited by 385
Apolipoprotein B: Structural and Metabolic Heterogeneity
Kane, J. P. (1983) · Annual Review of Physiology · doi:10.1146/annurev.ph.45.030183.003225 · Cited by 349
Weintraub, M. S., Zechner, R., Brown, A., Eisenberg, S., & Breslow, J. L. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113806 · Cited by 331
“The differences observed are not due to differential absorption of retinol as recently shown in the rat by Groot (58) or of the chronic or acute fat loads as shown here and in previous studies (59-62).”
BackgroundPradhan, A. D., Paynter, N. P., Everett, B. M., Glynn, R. J., Amarenco, P., Elam, M., Ginsberg, H., Hiatt, W. R., Ishibashi, S., Koenig, W., et al. (2018) · American Heart Journal · doi:10.1016/j.ahj.2018.09.011 · Cited by 319
Windler, E., & Havel, R. J. (1985) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34342-x · Cited by 314
Packard, C. J., Munro, A., Lorimer, A. R., Gotto, A. M., & Shepherd, J. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111644 · Cited by 298
Kissebah, A. H., Alfarsi, S., & Adams, P. W. (1981) · Metabolism · doi:10.1016/0026-0495(81)90064-0 · Cited by 295
Osborne, J. C., & Brewer, H. B. (1977) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60220-x · Cited by 285
Grundy, S. M., Mok, H. Y. I., Zech, L., Steinberg, D., & Berman, M. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109422 · Cited by 283
Pharmacology of competitive inhibitors of HMg-CoA reductase
Corsini, A. (1995) · Pharmacological Research · doi:10.1016/1043-6618(95)80042-5 · Cited by 277
Influence of nicotinic acid on metabolism of cholesterol and triglycerides in man
Grundy, S. M., Mok, H. Y., Zech, L., & Berman, M. (1981) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34737-4 · Cited by 270
Teng, B., Sniderman, A. D., Soutar, A. K., & Thompson, G. R. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112360 · Cited by 256
Inhibition of low density lipoprotein synthesis by dietary omega-3 fatty acids in humans.
Illingworth, D. R., Harris, W. S., & Connor, W. E. (1984) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.4.3.270 · Cited by 254
Cohn, J. S., Johnson, E. J., Millar, J. S., Cohn, S. D., Milne, R. W., Marcel, Y. L., Russell, R. M., & Schaefer, E. J. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)35345-1 · Cited by 248
Mistry, P., Miller, N. E., Laker, M., Hazzard, W. R., & Lewis, B. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110058 · Cited by 239
Self-citationShaikh, M., Wootton, R., Nordestgaard, B. G., Baskerville, P., Lumley, J. S., La Ville, A. E., Quiney, J., & Lewis, B. (1991) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.11.3.569 · Cited by 206
Self-citationIshibashi, S., Yamashita, S., Arai, H., Araki, E., Yokote, K., Suganami, H., Fruchart, J.-C., & Kodama, T. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.02.029 · Cited by 208
“Together with the results of longitudinal studies showing that remnant lipoproteins are strong risk factors for CHD [14], the preferential effects of K-877 on RemL-C, which reflects the combination of VLDL and chylomicron remnants, and apoB48, a marker for chylomicron remnants, may suggest that K877 has anti-atherogen…”
BackgroundInfluentialArai, H., Yamashita, S., Yokote, K., Araki, E., Suganami, H., & Ishibashi, S. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.03.032 · Cited by 124
Genetic Mutations Affecting Human Lipoproteins, Their Receptors, and Their Enzymes
Zannis, V. I., Kardassis, D., & Zanni, E. E. (1993) · Advances in Human Genetics 21 · doi:10.1007/978-1-4615-3010-7_3 · Cited by 78
Stalenhoef, A. F., Malloy, M. J., Kane, J. P., & Havel, R. J. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112632 · Cited by 70
Genetic Mutations Affecting Human Lipoprotein Metabolism
Zannis, V. I., & Breslow, J. L. (1985) · Advances in Human Genetics 14 · doi:10.1007/978-1-4615-9400-0_3 · Cited by 65
Ida, S., Kaneko, R., & Murata, K. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0845-x · Cited by 61
Role of the Liver in the Degradation of Lipoproteins
Cooper, A. D. (1985) · Gastroenterology · doi:10.1016/s0016-5085(85)80155-4 · Cited by 45
Metadata
- Authors
- Sigurdsson, G., Nicoll, A., & Lewis, B.
- Venue
- Journal of Clinical Investigation
- Published
- 1975-12-01
- Volume
- 56
- Issue
- 6
- Pages
- 1481-1490
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1994789322
- Cited by
- 308
- References
- 26
- FWCI
- 17.04
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.